Engineered nanopores detect proteins linked to ALS and other diseases
Original source
A self-assembled peptide forms α-helical nanopores for ultrasensitive biomarker profiling. (opens in a new tab)Compass summarised this from the study's abstract.
Researchers designed a peptide that self-assembles into adjustable nanoscale pores in lipid membranes. The pores detected disease-associated proteins, including peptides linked to amyotrophic lateral sclerosis (ALS), and could distinguish different pore sizes and protein forms. Larger pores also tracked the formation of alpha-synuclein assemblies associated with Parkinson’s disease.
Why this matters
The work suggests a possible laboratory platform for highly sensitive profiling of disease-related proteins. It may help researchers study protein forms and aggregation pathways, but the study does not show that the nanopores can diagnose ALS or guide treatment.
Limitations and context
This is a laboratory proof-of-concept study. The reported sensing was performed with peptides and protein assemblies, not with patient samples, and no clinical diagnostic or treatment benefit was demonstrated.